TP53-Y220Cp53

Bing Z Carter1, Po Yee Mak2, Edward Ayoub1

  • 1Section of Molecular Hematology and Therapy, Department of Leukemia, Houston, Texas, United States.

Blood
|July 3, 2025
PubMed
概括

在急性髓性白血病 (AML) 中的TP53-Y220C突变会产生一个口袋,PC14586的目标是恢复p53功能. 然而,MDM2和XPO1限制了apoptosis,venetoclax可以克服,这表明TP53-突变白血病的组合疗法.